Such limitations in mind, should overexpression of APP be a fundamental neurochemical dysfunction in FXS (or potentially ASD), several potential drugs may modulate levels of APP protein, such as posiphen and memantine104, 107, 108, 109. Here, APP is linked to fragile X syndrome.